Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT07864129

Volution of Pulmonary Artery Dimensions in Tetralogy of Fallot

Conditions: Tetralogy of Fallot (TOF), Congenital Heart Defects

Sex: All
Ages: 0 Years – 18 Years
Healthy volunteers: No
Enrollment: 400
Sponsor: University Hospital, Strasbourg, France

Location: Service de Pédiatrie 1 - CHU de Strasbourg - France Strasbourg

Summary

Tetralogy of Fallot is the most common cyanotic congenital heart disease. Management strategies vary between primary repair and staged approaches including palliative surgery. The development of pulmonary arteries is a key determinant in surgical decision-making. This multicenter retrospective observational study aims to evaluate the evolution of pulmonary artery dimensions using the Nakata index at key stages of patient management (birth, palliative surgery, and complete repair). The goal is to assess its predictive value in optimizing surgical strategy and improving outcomes in patients with Tetralogy of Fallot or pulmonary atresia with ventricular septal defect.

Eligibility Criteria

Inclusion Criteria: * Patients aged from birth to less than 18 years * Patients operated at Strasbourg or Bordeaux University Hospitals between 01/01/2010 and 31/12/2024 * Patient (or legal guardians) not opposing the reuse of medical data for research purposes Exclusion Criteria: * Patient expressing opposition to participation in the study * Parents/legal guardians or minor opposing data reuse * Specific clinical forms (VDDI) * Absence of subvalvular obstruction and absence of muscular resection

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07864129). StuddyBuddy aggregates publicly available trial information.